- Amazon (NASDAQ:AMZN) is reportedly planning a new "Diagnostics" brand that would offer tests for COVID-19, sexually transmitted infections, and clinical genomics, according to a Business Insider report.
- BI sources say Amazon will first launch its own COVID-19 test in June before expanding into other types of kits.
- The e-commerce giant also plans to launch a third-party marketplace for other at-home diagnostic services.
- Quest Diagnostics (DGX -2.7%) shares are down after the news.
- Last week, Quidel started selling its non-prescription QuickVue At-Home OTC COVID-19 Test through Amazon.
Quest Diagnostics stock dips as Amazon reportedly considers diagnostics business
Recommended For You
About DGX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| DGX | - | - |
| Quest Diagnostics Incorporated | ||